Anticancer agents interacting with membrane glucose transporters

被引：2
|
作者：
Granchi, C. [1 ]
Fortunato, S. [1 ]
Minutolo, F. [1 ]
机构：
[1] Univ Pisa, Dipartimento Farm, Via Bonanno 33, I-56126 Pisa, Italy
来源：
MEDCHEMCOMM | 2016年 / 7卷 / 09期
基金：
美国国家卫生研究院;
关键词：
PHLORETIN-INDUCED APOPTOSIS; GLUT1 HEXOSE TRANSPORTER; BREAST-CANCER CELLS; CYTOCHALASIN-B; LUNG-CANCER; IN-VITRO; PHASE-I; BIOLOGICAL EVALUATION; SILYBIN-PHYTOSOME; CURCUMIN ANALOG;
D O I：
10.1039/c6md00287k
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The altered metabolism observed in cancer cells generally consists of increased glucose uptake and glycolytic activity. This is associated with an overexpression of glucose transporter proteins (GLUTs), which facilitate glucose uptake across the plasma membrane and play a crucial role in the survival of cancer cells. Therefore, GLUTs are considered as suitable targets for treatment of cancer. Herein we review some of the most relevant GLUT inhibitors that have been recently developed as prospective anticancer agents.
引用
收藏
页码：1716 / 1729
页数：14
相关论文
共 50 条
  • [1] Glucose Transporters as a Target for Anticancer Therapy
    Pliszka, Monika
    Szablewski, Leszek
    CANCERS, 2021, 13 (16)
  • [2] Development of Anticancer Drugs Targeting Glucose Transporters (GLUTs)
    Sun, Ziru
    Liu, Shengnan
    Gao, Qingzhi
    PROGRESS IN CHEMISTRY, 2020, 32 (12) : 1869 - 1878
  • [3] Role of Glucose Transporters in Drug Membrane Transport
    Wang, Xin
    Guo, Kunkun
    Huang, Baolin
    Lin, Zimin
    Cai, Zheng
    CURRENT DRUG METABOLISM, 2020, 21 (12) : 947 - 958
  • [4] Natural-derived Polyphenols as Potential Anticancer Agents
    Spatafora, Carmela
    Tringali, Corrado
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2012, 12 (08) : 902 - 918
  • [5] Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents
    Yang, Jiahui
    Lv, Jianmei
    Cheng, Shuxian
    Jing, Tingyu
    Meng, Tenghao
    Huo, Dezhen
    Ma, Xin
    Wen, Ran
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (11) : 1265 - 1283
  • [6] Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives
    Lee, Sang Yeul
    Kim, Chul Young
    Nam, Tae-Gyu
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 5375 - 5392
  • [7] β-Carbolines as potential anticancer agents
    Aaghaz, Shams
    Sharma, Komal
    Jain, Rahul
    Kamal, Ahmed
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 216
  • [8] Small-Molecule Inhibition of Glucose Transporters GLUT-1-4
    Reckzeh, Elena S.
    Waldmann, Herbert
    CHEMBIOCHEM, 2020, 21 (1-2) : 45 - 52
  • [9] Coumarin: A Promising Scaffold for Anticancer Agents
    Kaur, Manjinder
    Kohli, Swarandeep
    Sandhu, Sonali
    Bansal, Yogita
    Bansal, Gulshan
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2015, 15 (08) : 1032 - 1048
  • [10] Targeting Key Transporters in Tumor Glycolysis as a Novel Anticancer Strategy
    Shi, Yunli
    Liu, Shengnan
    Ahmad, Shabir
    Gao, Qingzhi
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (06) : 454 - 466
12345